Concord Health Partners
VC Fund
Summit, United States
Concord Health Partners is a healthcare-focused investment firm with a strategic model that optimizes the alignment of interests between investors and portfolio companies. Concord is primarily focused on investing in healthcare companies that have the potential to enhance the value of care through products, services, technologies, and solutionsthat lower costs, improve quality, and/or expand access to care.Concord Health Partners was founded in 2017 by James T. Olsen and Joseph Swedish.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 74%
- Fund size:
- $2.2M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Concord Health Partners invests in
Stages Concord Health Partners invests in
Countries Concord Health Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
James T. Olsen
|
|||
Taylor Whitman
|
|||
Benson Jose
|
|||
Joseph R. Swedish
|
|||
Joseph Swedish
|
Investment Focus
Industry
- Health Care 15 (65%)
- Medical 10 (43%)
- Artificial Intelligence 6 (26%)
- Analytics 5 (22%)
- Machine Learning 3 (13%)
Stage
- Series B 6 (26%)
- Series A 4 (17%)
- Series C 4 (17%)
- Series D 3 (13%)
- Funding Round 3 (13%)
Country
- United States 16 (70%)
- Switzerland 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
James T. Olsen
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 11 | Find email | |
|
Taylor Whitman
Managing Director
|
Managing Director | Total investments: 2 | Find email | |
|
Benson Jose
COO/CFO
|
COO/CFO | Total investments: 0 | Find email | |
|
Joseph R. Swedish
Co-Founder & Partner
|
Co-Founder & Partner | Total investments: 2 | Find email | |
|
Joseph Swedish
Co-Founder & Partner
|
Co-Founder & Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Thyme Care
|
Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $97M / Series D / Sep 25, 2025 | |
Pieces
|
Pieces is a healthcare artificial intelligence and technology company that connects health systems and the community to address clinical and social determinants of health through community networks and intelligent software and services. Our solution interprets patient information in real-time and connects health systems and community-basedorganizations to support healthier outcomes, both inside and outside of hospital walls. Using cloud-based artificial intelligence with clinically-based natural language processing (NLP) and physician-supervised machine learning, our tools help streamline clinician workflows and improve patient outcomes. Combined, our solutions, Pieces Predict and Pieces Connect, create a comprehensive and unique solution for connected community health. | $25M / Venture - Series Unknown / Sep 10, 2024 | |
Loyal
|
Loyal’s AI-driven platform provides health systems with the tools needed to amplify patient feedback and guide patients through their digital journey. With its multi-disciplined team of engineers, marketers, and data scientists, Loyal partners with the nation’s leading health systems to promote patient loyalty through a smarter digital patientexperience. For more information please visit loyalhealth.com. | $33.5M / Series B / Jul 22, 2024 | |
|
Thyme Care
|
Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $55M / Series C / Jul 16, 2024 | |
Hicuity Health
|
Hicuity Health is the nation’s leading provider of high acuity telehealth services, contracted to provide care to more than 115 hospitals in 30 states on a 24 x 7 x 365 basis. Hicuity Health is a technology-enabled clinical services provider that employs cutting edge tele-technology, U.S. board-certified intensivists, multiple dedicated tele-caredelivery centers, and a proven implementation and client service approach to the benefit of patients, families, providers and hospitals. | Venture - Series Unknown / Jun 26, 2023 | |
Accelus
|
Accelus is committed to accelerating minimally invasive spine surgery through its procedure-enabling technology with broad accessibility to previously underserved markets. | $12M / Series D / Jul 12, 2022 | |
Iris Telehealth
|
Iris Telehealth is a leading provider of telepsychiatry services for community mental health centers, community health centers, hospitals, and health systems across the U.S.For Online inquiries contact email and phone number are available on their website. | $40M / Series B / Apr 14, 2022 | |
Post Acute Analytics
|
Post Acute Analytics provide total transparency for your patients’ journeys through post-acute care. It ensures patients receive the best care at an appropriate cost. Post Acute Analytics was founded by Saqib Akhter in 2018 and is based in Lewisville, Texas. | Series C / Mar 24, 2022 | |
MindMaze Group (Legacy)
|
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat and rehab patients. It develops medical grade virtual reality products to stimulate neural recovery. It also develops a platform to build intuitive human machine interfaces combining VR, computer graphics, brain imaging, and neuroscience.MindMaze offers MindMotionPRO, which provides patients with engaging and motivational virtual reality rehabilitation programs that support their recovery goals enabling them to follow a personalized exercise regimen prescribed by the rehabilitation expert. It promotes the ability of clinicians to design and personalize the dose and modality of a range of therapies and provides hospitals with the ability to optimize the delivery of rehabilitation therapy. MindMaze’s technology includes user interfaces, including a lightweight wearable head mounted display and 3D motion capture cameras that offer VR, gesture, and multiple object/user recognition and augmented reality capabilities, and medical grade technology enables new applications in gaming, brain machine control, and healthcare. It also offers motion capture technology and analysis, immersive virtual reality, and neurophysiological measurements and analysis solutions. Tej Tadi founded MindMaze on May 24, 2012. Its headquarters is in Lausanne in Switzerland with additional locations in Zürich and Ecublens in the same country and San Francisco in California in the United States. | $105M / Venture - Series Unknown / Feb 17, 2022 | |
Cylera
|
Cylera is a healthcare IoT cybersecurity and intelligence company used to protect healthcare organizations. The company provides a comprehensive platform and patented technology that delivers unified cybersecurity for asset management, risk analysis, and threat detection to deliver advanced healthcare IoT cybersecurity and intelligence solutionsfor the entire connected IoT environment. | $10M / Series A / Mar 18, 2021 | |
| See all 23 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Concord Health Partners invest in?
Concord Health Partners invests primarily in Health Care, Medical and Artificial Intelligence startups, most often at Series B and Series A stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Concord Health Partners?
Public channels for Concord Health Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Concord Health Partners?
The team at Concord Health Partners includes James T. Olsen (Founder & Managing Partner), Taylor Whitman (Managing Director) and Benson Jose (COO/CFO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
